Savvygen H. pylori & Antibiotic Resistance

The Savvygen™ H. pylori & Antibiotic Resistance is a qualitative test for the identification of H. pylori bacteria and a panel of 3 mutations related to its antibiotic resistance to Clarithromycin from stool samples of
symptomatic patients.

Antibiotic resistance in
Helicobacter pylori is a risk to
human health
• Helicobacter pylori (H. pylori) is one of the most common bacterial Infections worldwide and is closely associated with the incidence of chronic gastritis, peptic ulcers, and gastric cancer
• Current Management of H. pylori is based on a unified first line antibiotic treatment followed by second, and third-line treatment in case of eradication failure.
• The extent of eradication failure is estimated to be as high as 30%
• Eradication failure results mainly due to the bacteria resistance to the recommended antibiotic treatment regimen

Savvygen H. pylori & Antibiotic Resistance A First Line Screening RT-PCR Assay for H. pylori and it’s resistance to Clarithromycin from Stool Specimens
• Non-Invasive Test, minimizes patient discomfort
• Allows for optimal antibiotic treatment and better management of H. pylori
• Reduces Misuse of Antibiotics